[PDF][PDF] Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
M Tanimoto, H Saitoa - 2003 - academia.edu
We describe an interesting case of a patient with chronic myelogenous leukemia (CML) who
developed sustained severe bone marrow aplasia after 2 years and 11 months of interferon …
developed sustained severe bone marrow aplasia after 2 years and 11 months of interferon …
Recovery of normal hematopoiesis after severe bone marrow aplasia induced by interferon-α in a patient with chronic myelogenous leukemia
A Hishida, K Yamamoto, C Kato, T Yokozawa… - International journal of …, 2003 - Springer
We describe an interesting case of a patient with chronic myelogenous leukemia (CML) who
developed sustained severe bone marrow aplasia after 2 years and 11 months of interferon …
developed sustained severe bone marrow aplasia after 2 years and 11 months of interferon …
Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant
A Alabdulaaly, J Rifkind, H Solow… - Leukemia & …, 2004 - Taylor & Francis
A patient with chronic phase Philadelphia chromosome positive CML, developed severe
protracted bone marrow hypoplasia after interferon therapy. This complication did not …
protracted bone marrow hypoplasia after interferon therapy. This complication did not …
[PDF][PDF] Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia
Interferon-(IFN-) has been successfully employed in the treatment of several hematologic
malignancies. IFN-therapy can cause a variety of long-term side effects such as thyroid …
malignancies. IFN-therapy can cause a variety of long-term side effects such as thyroid …
Bone marrow cytogenetic complete remission achieved by interferon-α plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during …
A Gotoh, K Miyazawa, Y Uchida, G Sashida… - International journal of …, 2002 - Springer
We report a case of chronic myelogenous leukemia (CML) in which the bone marrow
achieved cytogenetic complete remission (CCR) achieved by treatment with interferon-α and …
achieved cytogenetic complete remission (CCR) achieved by treatment with interferon-α and …
Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow …
K Yano, K Iijima, H Sao, M Kobayashi - International journal of …, 1996 - europepmc.org
A patient with chronic myelogenous leukemia (CML) in chronic phase (CP) had been treated
with a syngeneic bone marrow transplantation (BMT). Cytogenetic remission was confirmed …
with a syngeneic bone marrow transplantation (BMT). Cytogenetic remission was confirmed …
Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia
M Talpaz, H Kantarjian, R Kurzrock, JU Gutterman - Cancer, 1992 - Wiley Online Library
In four patients with Philadelphia chromosome‐positive (Ph1) chronic myelogenous
leukemia (CML), bone marrow hypoplasia (three patients) and aplasia (one patient) …
leukemia (CML), bone marrow hypoplasia (three patients) and aplasia (one patient) …
Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation
P Borgies, A Ferrant, A Delannoy… - Bone marrow …, 1989 - pubmed.ncbi.nlm.nih.gov
We describe a patient with chronic granulocytic leukaemia (CGL) who relapsed after
allogeneic bone marrow transplantation (BMT). Interferon alpha 2b (IFN alpha 2b) induced …
allogeneic bone marrow transplantation (BMT). Interferon alpha 2b (IFN alpha 2b) induced …
Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia
L Parmeggiani, A Ferrant, J Rodhain… - European journal of …, 1987 - Wiley Online Library
2 patients with myelofibrosis and myeloid metaplasia had symptomatic splenomegaly and
were treated with interferon alpha‐2c (IFN alpha‐2c). The splenic pain and pressure …
were treated with interferon alpha‐2c (IFN alpha‐2c). The splenic pain and pressure …
Transient cytogenetic relapse in a Ph1-positive chronic myelogenous leukemia patient previously treated with alpha-interferon.
G Rege-Cambrin, A Guerrasio, P Scaravaglio, C Rosso… - Leukemia, 1992 - europepmc.org
Therapy with alpha-interferon (IFN alpha) can suppress the Ph1-positive hemopoiesis in a
percentage of patients with chronic myelogenous leukemia (CML). We used IFN alpha to …
percentage of patients with chronic myelogenous leukemia (CML). We used IFN alpha to …